The PPARα/γ Agonist, Tesaglitazar, Improves Insulin Mediated Switching of Tissue Glucose and Free Fatty Acid Utilization In Vivo in the Obese Zucker Rat
Figure 3
In vivo glucose utilization rate () in red quadriceps muscle as a function of plasma insulin levels under basal and hyperinsulinemic clamp conditions in Lean, Obese, and Tesaglitazar groups. Data points represent means ± SE ().
